期刊文献+

糖链抗原19-9和糖链抗原50对原发性肝癌的诊断价值

The value of CA19—9 and CA50 for diagnosing primary carcinoma of liver
暂未订购
导出
摘要 目的 :为提高对原发性肝癌 (PHC)的检出率。方法 :采用放射免疫法对 70例 PHC进行血清糖链抗原 19- 9(CA19- 9)和糖链抗原 50 (CA50 )检测。结果 :在 PHC患者中 CA19- 9和 CA50的阳性率分别为 50 .0 %和 54.3% ,在甲胎蛋白 (AFP)阴性的 PHC患者中 CA19- 9和 CA50的阳性率分别为 2 0 .8%和 2 5.0 % ,结论 :CA19- 9和 CA50对 PHC有较高的敏感性 ,且与 AFP可以互补 ,可提高 PHC的检出率 ,有较高的临床应用价值。 Objective:To improve the rate of detection on primary carinoma of live (PHC) Methods:CA19—9 and CA50 we r e detected in 70 patients with PHC by ra dioimmunoassay Results:The positive rates of CA19—9 and CA50 were 5 0 0% and 54 3% respectively in the patie nts with PHC Moreover:the positive rates of CA19—9 and CA50 were 20 8% and 25 0% respectively in the patients with PHC ,whose AFD were negative Conclusi o n:CA19—9 and CA50 have higher sen tivities in the patients with PHC and th ey can help each other with AFP,which ca n improve the rate of detection on PHC T hey have more valuable in clinical appli cation
出处 《河北医学》 CAS 2001年第7期617-619,共3页 Hebei Medicine
关键词 原发性肝癌 糖链抗原19-9 糖链抗原50 诊断 Primary carcimom a of liver CA19—9 CA50
  • 相关文献

参考文献5

二级参考文献2

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部